HOHL BENJAMIN (CHIEF FINANCIAL OFFICER) sold 13.7% of their position (6.02K shares) of ENLIVEN THERAPEUTICS, INC. on the open market
Open‑market sale worth $231.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/21/2026ACC: 0001882764-26-000009
Officer· CHIEF FINANCIAL OFFICER
Since Feb 2026
-6.02K
Net shares
Net seller
$231.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.02K acquired · 12.04K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.02K
Price / share
$14.85
Trade value
$89.37K
% of position
15.8%
10/19/2026
38K→44.02K
Common Stock
Direct
Shares
−6.02K
Price / share
$38.48
Trade value
$231.55K
% of position
13.7%
10/19/2026
44.02K→38K
Total
Net shares
+0.00
Net value
-$142.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/19/2026 | M · Option Exercise | +6.02K | $14.85 | $89.37K | 15.8% | 38K | 44.02K |
| Common Stock Direct | 10/19/2026 | S · Sale | −6.02K | $38.48 | $231.55K | 13.7% | 44.02K | 38K |
| Total | +0.00 | -$142.18K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
6.02K shares
Shares
−6.02K
Strike price
14.85
Held after
175K
Exercisable
—
10/19/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock6.02K shares | 10/19/2026 | M · Option Exercise | −6.02K | 14.85 | — | 175K |